Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch (ARILAI)

NCT02697045 PHASE4 COMPLETED

Nautralsitic, Open-label, Single Arm, Uncontrolled Study Evaluating the Effects of Long Acting Injectable (LAI) on Phychosocial Functioning Congitive Functioning and Patient Reported Acceptability of Treatment 'Reported Acceptability of Treatment' Regarding Quality of Life Subjective Well-being Under Neuroleptic Medication in Schizophrenia Patients

Details

Lead sponsor	Abdi İbrahim Otsuka
Phase	PHASE4
Status	COMPLETED
Enrolment	23
Start date	Wed Jan 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Mar 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Schizophrenia

Interventions

• Aripiprazole 400mg LAI

Countries

Turkey (Türkiye)